Anti-tumor agents 255: Novel glycyrrhetinic acid-dehydrozingerone conjugates as cytotoxic agents

被引:68
|
作者
Tatsuzaki, Jin
Taniguchi, Masahiko
Bastow, Kenneth F.
Nakagawa-Goto, Kyoko
Morris-Natschke, Susan L.
Itokawa, Hideji
Baba, Kimiye
Lee, Kuo-Hsiung [1 ]
机构
[1] Univ N Carolina, Sch Pharm, Nat Prod Res Labs, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Pharm, Div Med & Nat Prod Chem, Chapel Hill, NC 27599 USA
[3] Osaka Univ Pharmaceut Sci, Dept Pharmacognosy, Osaka 5691094, Japan
关键词
glycyrrhetinic acid; dehydrozingerone; conjugation; cytoloxicnv;
D O I
10.1016/j.bmc.2007.06.027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Esterification of glycyrrhetinic acid (GA) with dehydrozingerone (DZ) resulted in a novel cytotoxic GA-DZ conjugate. Based on this exciting finding, we conjugated eleven different DZ analogs with GA or other triterpenoids, including oleanoic acid (OA) or Ursolic acid UA). In an in vitro anti-cancer assay using nine different human tumor cell lines, most of the GA-DZ conjugates showed significant potency. Particularly, compounds 5, 29, and 30 showed significant cytotoxic effects against LN-Cap, 1 A9, and KB cells with ED50 values of 0.6, 0.8, and 0.9 mu M, respectively. Similar conjugates between DZ and OA or UA were inactive suggesting that the GA component is critical for activity. Notably, although GA-DZ conjugates showed potent cytotoxic activity, the individual components (GA and DZ analogs) were inactive. Thus, GA-DZ conjugates are new chemical entities and represent interesting hits for anti-cancer drug discovery and development. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6193 / 6199
页数:7
相关论文
共 50 条
  • [31] CELLTECH, SANKYO AGREE ON ANTI-TUMOR AGENTS
    DIXON, B
    BIO-TECHNOLOGY, 1984, 2 (12): : 1021 - 1021
  • [32] MUTAGENIC ACTIVITY OF NITROSOUREA ANTI-TUMOR AGENTS
    FRANZA, BR
    OESCHGER, NS
    OESCHGER, MP
    SCHEIN, PS
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1980, 65 (01) : 149 - 154
  • [33] THE SEARCH FOR ANTI-TUMOR AGENTS FROM PLANTS
    KINGHORN, AD
    PHARMACY INTERNATIONAL, 1982, 3 (11): : 362 - 366
  • [34] Alphaviruses and their derived vectors as anti-tumor agents
    Atkins, GJ
    Smyth, JWP
    Fleeton, MN
    Galbraith, SE
    Sheahan, BJ
    CURRENT CANCER DRUG TARGETS, 2004, 4 (07) : 597 - 607
  • [35] CYCLOSPORINS - IMMUNOSUPPRESSIVE AGENTS WITH ANTI-TUMOR ACTIVITY
    KREIS, W
    SORICELLI, A
    EXPERIENTIA, 1979, 35 (11): : 1506 - 1508
  • [36] Trypsinogen and chymotrypsinogen: potent anti-tumor agents
    Gonzalez-Titos, Aitor
    Hernandez-Camarero, Pablo
    Barungi, Shivan
    Marchal, Juan Antonio
    Kenyon, Julian
    Peran, Macarena
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (12) : 1609 - 1621
  • [37] MICROBIAL TRANSFORMATIONS OF NATURAL ANTI-TUMOR AGENTS
    ROSAZZA, JP
    LLOYDIA-THE JOURNAL OF NATURAL PRODUCTS, 1978, 41 (04): : 297 - 311
  • [38] MANAGEMENT OF TISSUE EXTRAVASATION OF ANTI-TUMOR AGENTS
    LARSON, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 416 - 416
  • [39] NEW DESIGNS IN CYCLOPHOSPHAZENES AS ANTI-TUMOR AGENTS
    LABARRE, JF
    LAHANA, R
    SOURNIES, F
    CROS, S
    FRANCOIS, G
    JOURNAL DE CHIMIE PHYSIQUE ET DE PHYSICO-CHIMIE BIOLOGIQUE, 1980, 77 (01) : 85 - 89
  • [40] ANALOGS OF HYCANTHONE AND LUCANTHONE AS ANTI-TUMOR AGENTS
    ARCHER, S
    ZAYED, AH
    REJ, R
    RUGINO, TA
    JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (09) : 1240 - 1246